ADHD Therapeutics Market Research Report Information by Drug Type (Stimulants and Non-Stimulants), Age Group (Pediatric & Adolescent and Adults), End-User (Specialty Clinics, Hospitals & Clinics, and others) and Region (the Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2032

Table of Contents

1. ADHD THERAPEUTICS MARKET REPORT PROLOGUE

2. ADHD THERAPEUTICS MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. ADHD THERAPEUTICS MARKET RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. ADHD THERAPEUTICS MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. ADHD THERAPEUTICS MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL ADHD THERAPEUTICS MARKET, BY DRUG TYPE

6.1. Overview

6.2. Stimulants

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1. Amphetamine

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Methylphenidate

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.3. Dextroamphetamine

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.4. Dexmethylphenidate

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.5. Lisdexamfetamine

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.6. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Non-Stimulants

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1. Atomoxetine

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Bupropion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3. Guanfacine

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.4. Clonidine

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL ADHD THERAPEUTICS MARKET, BY AGE GROUP

7.1. Overview

7.2. Pediatric and Adolescent

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Adults

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL ADHD THERAPEUTICS MARKET, BY END USER

8.1. Overview

8.2. Specialty Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3. Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

9. GLOBAL ADHD THERAPEUTICS MARKET, BY REGION

9.1. Overview

9.2. Americas ADHD Therapeutics Market

9.2.1. North America

9.2.1.1. US

9.2.1.2. Canada

9.2.2. Latin America

9.3. Europe ADHD Therapeutics Market

9.3.1. Western Europe

9.3.1.1. Germany

9.3.1.2. France

9.3.1.3. Italy

9.3.1.4. Spain

9.3.1.5. UK

9.3.1.6. Rest of Western Europe

9.3.2. Eastern Europe

9.4. Asia-Pacific ADHD Therapeutics Market

9.4.1. Japan

9.4.2. China

9.4.3. India

9.4.4. Australia

9.4.5. South Korea

9.4.6. Rest of Asia-Pacific

9.5. Middle East & Africa ADHD Therapeutics Market

9.5.1. Middle East

9.5.2. Africa

10. ADHD THERAPEUTICS MARKET COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global ADHD Therapeutics Market

10.5. Competitive Benchmarking

10.6. Leading Players in terms of Number of Developments in the Global ADHD Therapeutics Market

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch/Service Deployment

10.7.2. Mergers and Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix & Market Ratio

10.8.1. Sales & Operating Income 2020

10.8.2. Major Players R&D Expenditure 2020

10.9. Major Players Capital Market Ratio

11. ADHD THERAPEUTICS MARKET COMPANY PROFILES

11.1. Advanz Pharmaceutical

11.1.1. Company Overview

11.1.2. Product Overview

11.1.3. Financial Overview

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Eli Lilly and Company

11.2.1. Company Overview

11.2.2. Product Overview

11.2.3. Financial Overview

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. Highland Therapeutics Inc.

11.3.1. Company Overview

11.3.2. Product Overview

11.3.3. Financial Overview

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Janssen Pharmaceuticals, Inc.

11.4.1. Company Overview

11.4.2. Product Overview

11.4.3. Financial Overview

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. NEOS Therapeutics, Inc.

11.5.1. Company Overview

11.5.2. Product Overview

11.5.3. Financial Overview

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Pfizer Inc.

11.6.1. Company Overview

11.6.2. Product Overview

11.6.3. Financial Overview

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Novartis AG

11.7.1. Company Overview

11.7.2. Product Overview

11.7.3. Financial Overview

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Noven Pharmaceuticals, Inc.

11.8.1. Company Overview

11.8.2. Product Overview

11.8.3. Financial Overview

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Shire

11.9.1. Company Overview

11.9.2. Product Overview

11.9.3. Financial Overview

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Teva Pharmaceutical Industries Ltd.

11.10.1. Company Overview

11.10.2. Product Overview

11.10.3. Financial Overview

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

11.11. Impax Laboratories, LLC

11.11.1. Company Overview

11.11.2. Product Overview

11.11.3. Financial Overview

11.11.4. Key Developments

11.11.5. SWOT Analysis

11.11.6. Key Strategies

11.12. GlaxoSmithKline plc

11.12.1. Company Overview

11.12.2. Product Overview

11.12.3. Financial Overview

11.12.4. Key Developments

11.12.5. SWOT Analysis

11.12.6. Key Strategies

11.13. Purdue Pharma L.P.

11.13.1. Company Overview

11.13.2. Product Overview

11.13.3. Financial Overview

11.13.4. Key Developments

11.13.5. SWOT Analysis

11.13.6. Key Strategies

11.14. Others

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL ADHD THERAPEUTICS MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL ADHD THERAPEUTICS MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 6 GLOBAL ADHD THERAPEUTICS MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 8 NORTH AMERICA: ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 9 NORTH AMERICA: ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 10 US: ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 11 US: ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 12 US: ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 13 CANADA: ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 14 CANADA: ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 15 CANADA: ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 LATIN AMERICA: ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 17 LATIN AMERICA: ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 18 LATIN AMERICA: ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 19 EUROPE: ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 20 EUROPE: ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 21 EUROPE: ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 22 WESTERN EUROPE: ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 23 WESTERN EUROPE: ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 24 WESTERN EUROPE: ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 25 EASTERN EUROPE: ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 26 EASTERN EUROPE: ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 27 EASTERN EUROPE: ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 28 ASIA-PACIFIC: ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 29 ASIA-PACIFIC: ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 30 ASIA-PACIFIC: ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA: ADHD THERAPEUTICS MARKET, BY DRUG TYPE, 2020-2027 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA: ADHD THERAPEUTICS MARKET, BY AGE GROUP, 2020-2027 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA: ADHD THERAPEUTICS MARKET, BY END USER, 2020-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 ADHD THERAPEUTICS MARKET RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ADHD THERAPEUTICS MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ADHD THERAPEUTICS MARKET

FIGURE 4 GLOBAL ADHD THERAPEUTICS MARKET SHARE, BY DRUG TYPE, 2020 (%)

FIGURE 5 GLOBAL ADHD THERAPEUTICS MARKET SHARE, BY AGE GROUP, 2020 (%)

FIGURE 6 GLOBAL ADHD THERAPEUTICS MARKET SHARE, BY END USER, 2020 (%)

FIGURE 7 GLOBAL ADHD THERAPEUTICS MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: ADHD THERAPEUTICS MARKET SHARE BY REGION, 2020 (%)

FIGURE 8 NORTH AMERICA: ADHD THERAPEUTICS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 9 EUROPE: ADHD THERAPEUTICS MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 WESTERN EUROPE: ADHD THERAPEUTICS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 ASIA-PACIFIC: ADHD THERAPEUTICS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 MIDDLE EAST & AFRICA: ADHD THERAPEUTICS MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 GLOBAL ADHD THERAPEUTICS MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 14 ADVANZ PHARMACEUTICAL.: KEY FINANCIALS

FIGURE 15 ADVANZ PHARMACEUTICAL: SEGMENTAL REVENUE

FIGURE 16 ADVANZ PHARMACEUTICAL: REGIONAL REVENUE

FIGURE 17 ELI LILLY AND COMPANY: KEY FINANCIALS

FIGURE 18 ELI LILLY AND COMPANY: SEGMENTAL REVENUE

FIGURE 19 ELI LILLY AND COMPANY: REGIONAL REVENUE

FIGURE 20 HIGHLAND THERAPEUTICS INC.: KEY FINANCIALS

FIGURE 21 HIGHLAND THERAPEUTICS INC.: SEGMENTAL REVENUE

FIGURE 22 HIGHLAND THERAPEUTICS INC.: REGIONAL REVENUE

FIGURE 23 JANSSEN PHARMACEUTICALS, INC.: KEY FINANCIALS

FIGURE 24 JANSSEN PHARMACEUTICALS, INC.: SEGMENTAL REVENUE

FIGURE 25 JANSSEN PHARMACEUTICALS, INC.: REGIONAL REVENUE

FIGURE 26 NEOS THERAPEUTICS, INC.: KEY FINANCIALS

FIGURE 27 NEOS THERAPEUTICS, INC.: SEGMENTAL REVENUE

FIGURE 28 NEOS THERAPEUTICS, INC.: REGIONAL REVENUE

FIGURE 29 PFIZER INC.: KEY FINANCIALS

FIGURE 30 PFIZER INC.: SEGMENTAL REVENUE

FIGURE 31 PFIZER INC.: REGIONAL REVENUE

FIGURE 32 NOVARTIS AG: KEY FINANCIALS

FIGURE 33 NOVARTIS AG: SEGMENTAL REVENUE

FIGURE 34 NOVARTIS AG: REGIONAL REVENUE

FIGURE 35 NOVEN PHARMACEUTICALS, INC.: KEY FINANCIALS

FIGURE 36 NOVEN PHARMACEUTICALS, INC.: SEGMENTAL REVENUE

FIGURE 37 NOVEN PHARMACEUTICALS, INC.: REGIONAL REVENUE

FIGURE 38 SHIRE: KEY FINANCIALS

FIGURE 39 SHIRE: SEGMENTAL REVENUE

FIGURE 40 SHIRE: REGIONAL REVENUE

FIGURE 41 TEVA PHARMACEUTICAL INDUSTRIES LTD.: KEY FINANCIALS

FIGURE 42 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SEGMENTAL REVENUE

FIGURE 43 TEVA PHARMACEUTICAL INDUSTRIES LTD.: REGIONAL REVENUE

FIGURE 44 IMPAX LABORATORIES, LLC: KEY FINANCIALS

FIGURE 45 IMPAX LABORATORIES, LLC: SEGMENTAL REVENUE

FIGURE 46 IMPAX LABORATORIES, LLC: REGIONAL REVENUE

FIGURE 47 GLAXOSMITHKLINE PLC: KEY FINANCIALS

FIGURE 48 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

FIGURE 49 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

FIGURE 50 PURDUE PHARMA L.P.: KEY FINANCIALS

FIGURE 51 PURDUE PHARMA L.P.: SEGMENTAL REVENUE

FIGURE 52 PURDUE PHARMA L.P.: REGIONAL REVENUE